NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Morgan Stanley Cuts Harley-Davidson Rating on Weak Outlook

Morgan Stanley downgrades Harley-Davidson to Underweight with $25 price target, citing weak pricing power and challenging industry trends that overshadow recovery hopes.

Morgan Stanley Cuts Harley-Davidson Rating on Weak Outlook
Photo by Bruno Kelzer on Unsplash
Already have an account? Sign in.
10/27/2025 · 5:24 AM
HOG
/ Read more

Feed↓

SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming
Featured/ 06/27/2026 · 1:18 AM

SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming

Despite the massive demand boost, analysts remain cautious, citing the company’s $4.9 billion net loss last year and concerns over valuation.

/ Subscriber only
Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised
06/26/2026 · 4:53 PM

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised

The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.

/ Subscriber only
Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle
06/26/2026 · 3:43 PM

Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle

Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe